Alexandre Akoulitchev

Company: Oxford BioDynamics plc

Job title: Chief Scientific Officer

Seminars:

Liquid Biopsy with 3D Genomic Biomarkers as A Clinical Tool For Diagnosis, Prognosis & Disease Understanding In ALS 8:30 am

3D Genomic EpiSwitch® blood-based biomarkers: development of blood based clinical tests for early diagnosis, prognosis and prediction of response to treatment ALS diagnostic and prognostic EpiSwitch® tests: from development to deployment in MTPA Radicava trial EpiVerseTM profiling of ALS regulatory 3D genomic footprint: from ALS subtypes to neuro-inflammation and strong predictors as therapeutic targetsRead more

day: Day One AM